A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis
Clinical trial NCT03395704 · COMPLETED
Trial details
- NCT number
- NCT03395704
- Sponsor
- La Jolla Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2019-10-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.